Charité - Universitätsmedizin Berlin

Hospital


Location: Berlin, Germany (DE) DE

ISNI: 0000000122184662

ROR: https://ror.org/001w7jn25

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Native t1 mapping magnetic resonance imaging as a quantitative biomarker for characterization of the extracellular matrix in a rabbit hepatic cancer model (2020) Keller S, Borde T, Brangsch J, Adams LC, Kader A, Reimann C, Gebert P, et al. Journal article Rehabilitation in Heart Failure Rehabilitation bei Herzinsuffizienz (2020) Reibis RK, Schlitt A, Langheim EH, Guha M, Halle M, Boscheri A, Hegeler-Molkewehrum C, Voeller H Journal article Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system (2020) Schmidt M, Degenhardt T, Fasching P, Lueftner D, Mueller V, Thomssen C, Schem C, et al. Conference contribution Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets (2020) Matsushita K, Jassal SK, Sang Y, Ballew SH, Grams ME, Surapaneni A, Arnlov J, et al. Journal article Frühgeborene an der Grenze der Lebensfähigkeit (Entwicklungsstufe S2k, AWMF-Leitlinien-Register Nr024/019, Juni 2020) (2020) Bührer C, Felderhoff-Müser U, Gembruch U, Hecher K, Kainer F, Kehl S, Kidszun A, et al. Journal article Use of a molecular Registry (PRAEGNANT) for Patient-Selection and Biomarker-Analysis for the SHERBOC Study (2020) Hübner H, Kurbacher C, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Conference contribution The Work- and Further Training Situation of young Doctors in Further Training in Gynecology - A Standpoint (2020) Lermann J, Knabl J, Neimann J, Schulte K, Proske K, Schott S, Raspe M Conference contribution Progression-free survival and overall survival in patients with advanced her2-positive breast cancer treated with trastuzumab emtansine (T-dm1) after previous treatment with pertuzumab (2020) Michel LL, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, Häberle L, et al. Journal article Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany (2020) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Influence of CDK4/6 inhibitors on the peripheral immune response in hormone receptor-positive breast cancer (2020) Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, Hennig S, Schaper S, Brucker S, et al. Conference contribution